Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II multicenter study evaluating predictive markers of response in breast cancer
2009-011037-27Phase 2Completed
- Sponsor
- Instituto Científico Tecnológico de Navarra
- Start
- Apr 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of bevacizumab in breast cancer, sponsored by Instituto Científico Tecnológico de Navarra. Primary endpoint: Efficacy. Started Apr 2009; status: completed.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2009-011037-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011037-27.